NCT01452971

Brief Summary

Environmental carcinogens such as polycyclic aromatic hydrocarbons (PAHs) were reviewed as the major risk factors for lung cancer development. In this proposal, the investigators collected fifteen kinds of major PAHs and the investigators would like to perform the following studies:

  1. 1.Study the gene expression and subcellular localization of GNMT in the normal-tumor tissue pairs of lung cancer patients.
  2. 2.Study the associations of the polymorphisms of GNMT in lung cancer patients and the susceptibility to lung cancer;
  3. 3.To assess the allelic loss at GNMT and determined the LOH rate of GNMT in the normal-tumor tissue pairs of lung cancer patients.
  4. 4.Study the associations of the copy number variation (CNV) of GNMT and the susceptibility to lung cancer;
  5. 5.Study the interaction between GNMT and polycyclic aromatic hydrocarbons (PAHs) in lung cancer cell lines.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

October 13, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 17, 2011

Completed
Last Updated

October 17, 2011

Status Verified

October 1, 2011

First QC Date

October 13, 2011

Last Update Submit

October 14, 2011

Conditions

Keywords

tumor susceptibility geneglycine N-methyltransferase (GNMT)polycyclic aromatic hydrocarbons (PAHs)lung cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

primary care clinic

You may qualify if:

  • Participant is a lung cancer patient.

You may not qualify if:

  • Participant is under 18 years old.
  • Participant is not a lung cancer patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2011

First Posted

October 17, 2011

Study Start

October 1, 2011

Last Updated

October 17, 2011

Record last verified: 2011-10